Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the effects of fondaparinux on biochemical parameters and clinical events according to different duration of treatment in heart failure patients (III-IV NYHA). Primary end-point: circulating D-dimer plasma levels 2 months after enrolment
Inclusion criteria
- heart failure patients (III-IV NYHA)